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ABSTRACT 
 
Long term potentiation (LTP) in the hippocampus is considered a cellular 
basis of learning memory.  Sleep deprivation, especially rapid eye movement 
(REM) sleep deprivation, impairs learning and memory as well as LTP.  Since most 
of the previous LTP studies were conducted in the in vitro condition, the full 
consequences of sleep deprivation (SD) in the living animal are yet to be found. 
Thus, I tested hippocampal LTP in living animals after 5 days of REM sleep 
deprivation to determine the effect of SD in vivo.  SD also disrupts growth 
hormone (GH) release.  Recent evidence indicates that GH regulates cognitive 
and hippocampal synaptic function.  However, the relationship between GH and 
synaptic function during SD is not well established.  Since the N-methyl-D-
aspartate receptor (NMDAR) has an important role in inducing LTP, I hypothesized 
that loss of normal GH signals during SD would impair synaptic NMDAR 
expression and function, and treating SD animals with GH would restore normal 
NMDAR expression and function.  To test my hypothesis, I treated animals with 
GH during 3 days of SD, and tested NMDAR dependent hippocampal synaptic 
II 
 
 
functions and measured synaptic expression of NMDAR subunits.  In addition, I 
measured corticosterone concentration in control and sleep deprived animals to 
determine stress levels in each treatment.  My results showed that LTP in vivo 
was impaired after 5 days of SD.  NMDAR function was impaired and there was a 
selective loss of NR2B NMDAR subunits from synaptic membranes.  These 
changes in NMDAR function and expression can explain the LTP impairment 
caused by SD.  In agreement with my hypothesis, the LTP and NMDAR 
impairments were reversed by GH treatment during SD.  Finally, there was no 
difference in corticosterone concentration between control and SD animals, 
demonstrating that differences in stress were not responsible for any of the 
changes I observed during SD. 
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Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hippocampus and Synaptic plasticity  
 
The hippocampus has been recognized as playing a vital role in the 
formation of memory since the observations of Milner in 1957.  Milner studied a 
patient, known as H.M., who had a bilateral hippocampal resection as a treatment 
for intractable epilepsy.  As a result of his surgery, H.M. suffered dense, 
anterograde amnesia through the end of his life in 2008 (Scoville and Milner 1957).  
In 1982, Morris et al. used an animal model to confirm that the hippocampus is 
needed for spatial memory.  Morris et al. surgically removed the hippocampus and 
then tested spatial memory in a water maze.  Animals with hippocampal lesions 
had impaired spatial memory (Morris, Garrud et al. 1982). 
 
The hippocampus is a cylindrical structure located inside the temporal lobe 
of the cerebral cortex.  Humans and other mammals have two hippocampi, one in 
each side of the brain.  The hippocampus proper can be divided into four regions, 
CA1 to CA4 (from the latin cornu Ammon, or Ammon’s horn).  The dentate gyrus, 
the subiculum and the entorhinal cortex are included in the more general term 
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hippocampal formation or hippocampal region.  The main inputs to the 
hippocampus and dentate gyrus arise from the entorhinal cortex, the septal region, 
and the contralateral hippocampus.  The output or principal neurons of the 
hippocampus are the pyramidal neurons found in CA3 to CA1 region.  The 
pyramidal neurons in the CA1 region receive input mostly from CA3 then project 
heavily to neurons in the adjacent subiculum.  The axons from the CA3 neurons 
which synapse onto CA1 pyramidal neurons are called Schaffer collateral.  The 
Schaffer collateral/CA1 pyramidal neurons synapses have been studied most 
extensively for synaptic plasticity in the hippocampus (Shepherd, 1990). 
 
 
Figure 1. Cross-section of hippocampal formation 
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It is widely believed that a long-lasting change in synaptic function in the 
hippocampus is the cellular basis of learning and memory.  The most thoroughly 
characterized example of such synaptic plasticity is long-term potentiation (LTP) 
(Malenka and Nicoll 1999).  LTP was first demonstrated by Bliss and Lomo in 
1973.  They reported that brief high-frequency stimulation of excitatory pathways 
in the hippocampus caused an increase in synaptic strength that last for hours 
(Bliss and Lomo 1973).  Induction of LTP requires the simultaneous activation of 
both pre- and postsynaptic neurons.  Excitatory post-synaptic potentials (EPSPs) 
are measured as an indicator of postsynaptic activity.  A single stimulation given to 
the presynaptic axons produces a relatively brief depolarization of the postsynaptic 
cell, whereas high-frequency (tetanic) stimulation (i.e., 100Hz, for 1s, which is 
commonly used to induce LTP) of the presynaptic axons produces a longer and 
larger compound, or summed, EPSP.  Signaling events triggered during the 
postsynaptic response to high frequency presynaptic stimulation are essential for 
LTP induction.  LTP may last for hours or days and this is the reason why it is 
called long-term potentiation (Craver 2003). 
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Figure 2. LTP in Hippocampal CA1 Region 
 
 
Over the last couple of decades, knowledge of the mechanisms underlying 
LTP has increased rapidly.  It is well established that increased calcium 
concentration in the postsynaptic cell during high frequency stimulation is required 
to induce LTP (Malenka and Nicoll 1999).  The postsynaptic N-methyl-D-aspartate 
glutamate receptor (NMDAR) plays an important role as a calcium entry pathway 
during LTP induction.  The neurotransmitter glutamate, which is released from 
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presynaptic terminals in the hippocampus, binds to two major classes of 
postsynaptic receptor:  NMDA and AMPA (α-amino-3-hydroxyl-5-methyl-4-
isoxazole-propionate).  The NMDA receptor is blocked by magnesium at resting 
membrane potentials and becomes activated only during coincident membrane 
depolarization and glutamate binding, which occurs during the high frequency 
stimulation used to induce LTP.  Activated NMDA receptors are calcium 
permeable and therefore increase intracellular calcium levels in the postsynaptic 
cells during LTP induction.  Increased calcium concentration in the postsynaptic 
cells after NMDA receptor activation leads to activation of several downstream 
signaling molecules.  One of these molecules is calcium-calmodulin-dependent 
protein kinase II (CaMKII).  It has been suggested that CaMKII becomes 
persistently activated through autophosphorylation during LTP induction, and this 
autophosphorylation helps to maintain LTP for several hours following induction 
(Lisman and Goldring 1988; Bliss and Collingridge 1993).  In addition to 
phosphorylating itself, CaMKII phosphorylates AMPA receptors and thereby 
regulates their activity.  AMPA receptors are permeable to sodium and potassium, 
and this permeability allows these receptors to rapidly change postsynaptic 
6 
 
 
 
membrane potential. Phosphorylation of AMPA receptors by CaMKII increases 
conductance which results in enhancement of AMPA receptor-mediated 
postsynaptic responses during LTP (Benke, Luthi et al. 1998).  In addition, CaMKII 
controls insertion of new AMPA receptors into the postsynaptic membrane by 
activating rasGAP which stimulates mitogen activated protein kinase (MAPK, also 
known as extracellular signal-regulated kinase or ERK) and phosphatidylinositol 3-
kinase (PI3K) (Malinow and Malenka 2002).  Increased calcium concentration in 
the postsynaptic cell during LTP induction also induces presynaptic modification.  
Presynaptic modification is thought to occur through formation of a retrograde 
messenger in postsynaptic neurons which is released to alter presynaptic function.  
Nitric oxide (NO) is the leading candidate for this retrograde messenger.  NO is 
released from cultured neurons following NMDA receptor activation (Garthwaite, 
Charles et al. 1988), and inhibitors of NO synthase block the induction of LTP 
(O'Dell, Hawkins et al. 1991; Haley, Wilcox et al. 1992).  Although a complete 
description of the mechanisms of LTP induction does not yet exist, and some areas 
of controversy remain, the role of postsynaptic calcium in activating downstream 
signaling molecules is well established. 
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Figure 3. Mechanisms of LTP induction (Kandel, ER, JH Schwartz and TM 
Jessell (2000) Principles of Neural Science. New York: McGraw-Hill.) 
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Since the NMDA receptor has a critical role in inducing LTP, the relationship 
between LTP and learning and memory was tested by disrupting NMDA receptor 
function and looking for memory impairment.  In 1986 Morris et al. showed that 
blocking NMDA receptors with the NMDA receptor antagonist, AP5 (5-amino-
phosphopentanoic acid, or APV, 5-amino-phosphovaleric acid), inhibited both LTP 
and spatial learning (Morris, Anderson et al. 1986). Subsequently, Tsien et al. 
(1996) examined genetically manipulated mice in which the NMDA receptor was 
deleted in hippocampal area CA1 and reported that LTP as well as spatial memory 
were impaired (Tsien, Huerta et al. 1996).  Manipulation of downstream targets of 
NMDAR receptor activation was also done to test the relationship between LTP 
and learning and memory.  For example, it has shown that inhibition of ERK by a 
selective MAPK cascade inhibitor, such as PD098059, results in impaired induction 
of LTP (English and Sweatt 1997) as well as spatial memory (Blum, Moore et al. 
1999).  These studies have shown that disruption of components of the LTP 
signaling pathway impairs learning and memory. Because of these findings, LTP is 
considered a cellular basis of learning and memory.  
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Sleep, learning and memory, and LTP 
The role of sleep in cognitive and brain function remains largely unknown 
even though there has been a rapid increase in understanding of the processes 
which generate and maintain sleep.  A number of hypotheses have been 
proposed to link sleep and brain function involving, for example, energy 
conservation, brain thermoregulation, brain detoxification, and tissue restoration 
(Beatty 2000).  Another hypothesis proposes that sleep periods are favorable for 
brain plasticity and for learning and memory (Blissitt 2001; Maquet 2001).  A 
number of studies have shown that sleep has a beneficial effect and sleep 
deprivation (SD) has a negative effect on learning and memory.  In 1977, Benson 
and Feinberg tested memory after 8 hr of sleep or SD. The subjects learned a 
paired-associate list of common nouns before sleep or SD treatment.  After 8 
hours of sleep or SD treatment, subjects had to recall each associated noun when 
the paired noun was presented. In this study the subjects who slept after learning 
recalled better than those who had been sleep deprived (Benson and Feinberg 
1977).  More recently, Harrison and Horne showed that SD impaired temporal 
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(recency discrimination) memory.  The subjects learned two sets of 12 faces 
which were introduced as List A and List B (total 24 faces). During the test session, 
24 faces (either from List A or List B) were randomly given to the subjects and the 
subjects were asked to specify whether the face was included in List A or List B.  
The results showed that the SD group scored significantly lower than control group 
indicating that temporal (recency) memory was impaired after 36 hr of SD (Harrison 
and Horne 2000).  
 
Sleep consists of several distinct phases. Stages 1 to 4 are called non- 
rapid eye movement (REM) or slow wave sleep (SWS).  Each stage is 
distinguished by distinct patterns of EEG (electroencephalogram) activity.  Stage 1, 
the lightest sleep, is characterized by short periods of theta activity (4-7 Hz). Stage 
2 is marked by the appearance of sleep spindles which are rhythmic bursts of 12 to 
15 Hz EEG activity. Stages 3 and 4 show low frequency (1-4 Hz) delta waves. 
Stage 4 is the deepest stage of slow wave sleep, from which arousal is most 
difficult.  The final stage is REM sleep in which the EEG is low amplitude and 
desynchronized, very similar to the waking EEG.  However, unlike the waking or 
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non-REM sleep states, periodic suppression of muscle tone (except for ocular 
muscles), frequent bursts of rapid eye movement and vivid dreams occur during 
REM sleep.  In humans, each of these stages occurs five to six times nightly with 
a complete cycle of stages lasting 60 to 90 minutes (Beatty 2000).  
 
The role of each sleep stage in the learning and memory process is not 
clear.  However, many experimental findings indicate that REM sleep has an 
important role in the learning and memory process (Siegel 2001).  One line of 
evidence supporting a role for REM sleep in learning and memory is the increased 
duration or density of REM sleep which is observed after learning.  Mandia et al. 
(1998) recorded EEG activities during the sleep periods of subjects who learned 
Morse Code before the onset of sleep.  They found out that learning prior to sleep 
increased the number and duration of REM sleep episodes (Mandai, Guerrien et al. 
1989).  Smith and Lapp (1991) also recorded sleep in students after an intensive 
exam period.  They found no change in REM sleep duration, but found an 
increase in the density of REM sleep eye movement (Smith and Lapp 1991).  A 
second line of evidence indicating the importance of REM sleep in learning and 
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memory is the finding that REM sleep deprivation impairs spatial reference memory.  
Many of these studies have used animal models to test the effect of REM sleep 
deprivation on learning and memory.  The ‘inverted flower pot’ or pedestal 
technique is perhaps the most widely used method for inducing REM sleep 
deprivation in animals.  Animals, typically rats, are placed on a small platform (in 
the original studies, an inverted flower pot) surrounded by water.  Upon entry into 
REM sleep, the rats lose muscle tone and fall into the water.  Control animals are 
placed either on large platforms or are housed in normal cages (Horne and 
McGrath 1984).  Animals also require special methods for testing learning and 
memory.  The Morris water maze is widely used to investigate memory in animals.  
In the Morris water maze, the subject must find a platform hidden below the 
surface of water which has been made opaque by the addition of dye or nonfat 
powdered milk.  Animals receive repeated trials with the hidden platform kept in 
the same location.  The time required to find the hidden platform is used as a 
measure of spatial memory (Brandeis, Brandys et al. 1989).  In 1997, Youngblood 
et al, used the ‘inverted flower pot’ method to induce REM sleep deprivation in rats 
and tested memory using the Morris water maze technique.  They reported a 
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significant decrement in performance in the water maze task after 48hr of REM 
sleep deprivation (Youngblood, Zhou et al. 1997).  
 
In addition to disrupting learning and memory, SD impairs synaptic plasticity 
in the hippocampus. In 2002, Campbell et al. showed that LTP was impaired in 
hippocampal slices from animals deprived of all sleep for 12hr (Campbell, Guinan 
et al. 2002).  The effect of selective REM sleep deprivation on hippocampal 
synaptic plasticity and LTP has also been tested.  McDermott et al. showed that 
72hr of REM sleep deprivation impaired spatial memory in rats.  In addition, they 
showed that CA1 neuron excitability and LTP were inhibited by SD (McDermott, 
LaHoste et al. 2003).  In 2003,  Davis et al. reported that maintenance of LTP 
was attenuated in hippocampal slices from 24, 48 and 72hr sleep deprived rats, 
and  the induction of LTP was impaired by the two longer durations of REM sleep 
deprivation (48 and 72 hr) (Davis, Harding et al. 2003).  These findings suggest 
that sleep, especially REM sleep, is required for learning and memory and synaptic 
plasticity in the hippocampus.  
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Growth hormone (GH) and Cognitive function 
GH, a large 191 amino acid polypeptide (22 Kda), is secreted from 
somatotroph cells in the anterior pituitary.  GH is essential for somatic growth and 
metabolism (Gotherstrom, Svensson et al. 2001).  Synthesis and secretion of GH 
are regulated by two hypothalamic neurohormones: growth hormone-releasing 
hormone (GHRH), which simulates, and somatostatin, which inhibits GH.  GHRH 
and somatostatin are secreted into the pituitary portal circulation at the median 
eminence, and they are carried into the anterior pituitary by the blood. GH 
secretion is also stimulated by exercise (Berg and Bang 2004), starvation, (Tanaka, 
Nakahara et al. 2004) and sleep (Obal and Krueger 2004; Steiger 2007), whereas 
aging decreases GH secretion (Corpas, Harman et al. 1993).  GH has both direct 
and indirect actions on target tissues. Indirect effects of GH are mediated mainly by 
insulin-like growth factor I (IGF-1).  IGF-1 is produced in response to GH 
stimulation in the liver and at other sites of GH action.  IGF-1 in turn, feeds back 
on the hypothalamus and pituitary to inhibit GH release.  
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Figure 4. Schematic diagram of the control of growth hormone secretion 
(modified from Reichlin S: Neuroendocrinology. In : Williams Textbook of 
Endocrinology, 7th ed. Wilson JD. Foster DV [editors]. Saunders, 1985) 
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The GH receptor (GHR) is expressed in several regions of the brain 
including the hippocampus.  Immunohistochemistry and in situ hybridization in the 
neonatal rabbit brain revealed the strongest GHR signal in the cerebral cortex and 
the pyramidal cells of the hippocampus (Lobie, Garcia-Aragon et al. 1993).  
Previously, it was thought that the blood-brain barrier (BBB) was almost 
impermeable for most peptide hormones including GH.  However, in recent years 
the ability of GH to cross the BBB has been recognized (Coculescu 1999; Aberg, 
Brywe et al. 2006).  In 1995, Johnsson et al. showed increased GH concentration 
in the cerebrospinal fluid in GH-deficiency patient after recombinant human GH 
(rhGH) treatment (Johansson, Larson et al. 1995).  In addition, GHRs are present 
in the choroid plexus at higher levels that in any other brain tissue, and these 
receptors may contribute to a transport system for moving GH across the blood- 
cerebrospinal fluid (CSF) barrier (Lai, Emtner et al. 1991).  Others have provided 
direct evidence that GH enters the brain through a non-saturable process, 
suggesting that GH crosses the BBB by simple diffusion despite its large molecular 
weight (Pan, Yu et al. 2005).  IGF-1 is also expressed widely in the brain (D'Ercole, 
Ye et al. 1996).  In the CNS, IGF-1 promotes cell proliferation, cell migration, and 
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cell differentiation during brain development (Anlar, Sullivan et al. 1999).  It is well 
established that IGF-1 reaches the CNS from the peripheral blood stream by a 
specific carrier in the BBB (Pan, Yu et al. 2005).  However, it also has been 
reported that IGF-1 is locally produced in the brain (Sun, Al-Regaiey et al. 2005), 
suggesting that GH can regulate brain function directly through interaction with 
GHRs and indirectly through local production of IGF-1. 
 
Recent evidence indicates that GH has effects on cognitive function 
(Nyberg 2000; Aberg, Brywe et al. 2006).  Learning and memory impairment is a 
well known feature of GH deficiency in humans and a number of studies have 
shown that GH treatment improves learning and memory impairment in GH 
deficiency.  Deijen et al. treated child-onset GH deficiency patients with GH and 
found that memory was improved after 1 year of treatment (Deijen, de Boer et al. 
1998).  With the same group of patients, Arwert et al. (2005) also reported that 
improved memory was maintained even after 10 years of GH treatment (Arwert, 
Deijen et al. 2005).  In 2006, Le Greves, et at. treated hypophysectomized rats 
with recombinant human GH (rhGH) for 9 days.  During treatment, they tested 
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memory using the Morris water maze and found that memory was improved with 
GH treatment in the hypophysectomized rats (Le Greves, Zhou et al. 2006).  In 
addition, aging both inhibits GH release and impairs learning and memory. GH 
treatment improves spatial learning in aged rats (Ramsey, Weiner et al. 2004).  
Twenty-four month old rats were injected with porcine GH for 4 months and then 
spatial learning was tested.  The GH treated aged rats showed improved spatial 
learning compared with saline treated aged rats. Moreover, there was no difference 
in learning between the GH treated 24 month old aged rats and saline injected 4 
month old adult rats (Ramsey, Weiner et al. 2004). 
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GH and SD 
GH is secreted in surges throughout the day but the largest surge of GH 
secretion occurs during sleep (Obal and Krueger 2004; Steiger 2007).  Given the 
association between sleep and GH secretion, it is not surprising that sleep 
deprivation (SD) suppresses GH secretion.  Kimura and Tsai (1984) investigated 
GH secretion in rats.  They showed that GH secretion peaked during sleep onset 
and SD during this period prevented the normal high-level GH pulse (Kimura and 
Tsai 1984).  In 2000, Brandenberger et al. showed a similar suppression of GH 
secretion during SD in human subjects (Brandenberger, Gronfier et al. 2000).    
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Figure 5. Effect of SD on 24 h GH secretion (Brandenberger et al. 2000) 
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 Taken together, the previous studies have demonstrated that SD impairs 
NMDAR dependent hippocampal synaptic plasticity as well as GH release.  
Although both SD and GH have effects on cognitive and synaptic function, the 
effect of GH on synaptic function during SD has not been well investigated.  To 
determine the effect of SD and GH on synaptic plasticity in the hippocampus, I 
addressed three related questions.  First, does SD impair LTP in the hippocampus 
in vivo?  To answer this question, I implanted electrodes directly into rat 
hippocampus and tested LTP after 5 days of REM sleep deprivation.  Second, I 
hypothesized that if decreased GH release during SD is responsible for impairment 
of synaptic plasticity in the hippocampus, then GH treatment during SD should 
prevent this impairment.  This hypothesis was tested by examining NMDAR 
function, which has an important role in inducing LTP, in hippocampal brain slices 
prepared from SD or control animals that had received GH or saline injections.  To 
determine if GH treatment affected synaptic NMDAR expression, I used western 
blotting to measure NMDAR subunit levels in synaptosomal membrane fractions.  
And last, I asked whether the apparent effect of SD on synaptic plasticity might 
have resulted from stress which can be caused by SD procedures.  To answer this 
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question, I compared the concentration of corticosterone, a stress related hormone, 
in serum from SD and control animals. 
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Chapter 1 
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Introduction 
Long-term potentiation (LTP) in the hippocampus is widely used to study 
the cellular basis of learning and memory (Malenka and Nicoll 1999).  LTP was 
first reported by Bliss and Lomo.  They demonstrated that a brief high-frequency 
stimulation to excitatory pathways in the hippocampus caused an increase in 
synaptic strength that lasted for hours (Bliss and Lomo 1973).  Activation of 
NMDA receptors and increased calcium concentration in the postsynaptic cell is 
required for induction of LTP (Malenka and Nicoll 1999).  A number of studies 
have shown that blocking NMDA receptors impairs LTP as well as learning and 
memory (Morris, Anderson et al. 1986; Tsien, Huerta et al. 1996; English and 
Sweatt 1997; Blum, Moore et al. 1999).  In 1986, Morris et al. showed that 
blocking NMDA receptors with the NMDA receptor antagonist, AP5,  inhibited both 
LTP and spatial learning (Morris, Anderson et al. 1986).  Subsequently, Tsien et al. 
(1996) examined genetically manipulated mice in which the NMDA receptor was 
deleted in hippocampal area CA1.  They reported that LTP as well as spatial 
memory were impaired (Tsien, Huerta et al. 1996).  These results indicate that the 
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learning and memory process and LTP induction share the same synaptic 
mechanisms.  
 
Despite our increasing understanding of the processes generating and 
maintaining sleep, its function remains elusive.  Among several hypotheses, it was 
suggested that sleep is involved in the brain plasticity which occurs during memory 
formation (Blissitt 2001; Maquet 2001).  Sleep can be broadly considered as two 
states: rapid eye movement (REM) sleep and non REM sleep. REM sleep is 
characterized by periodic muscle suppression, frequent bursts of rapid eye 
movement and vivid dreaming.  In addition, a low amplitude and desynchronized 
EEG, very similar to waking EEG activity, is prominent during REM sleep.  By 
contrast, during non-REM sleep, the cortical EEG is slowed overall and progresses 
from intermittent spindling to a predominance of slow waves (Graves, Pack et al. 
2001).   
 
Several lines of evidences have suggested that REM sleep might play an 
important role in memory formation.  It has been shown that REM sleep duration 
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and density is increased after learning (Mandai, Guerrien et al. 1989; Smith and 
Lapp 1991) and REM sleep deprivation impaired hippocampal dependent learning 
and memory (Youngblood, Zhou et al. 1997).  REM sleep deprivation also impairs 
LTP in the hippocampus.  Davis et al. (2003) reported that maintenance of LTP 
was attenuated in hippocampal slices from 24, 48 and 72hr sleep deprived rats and 
the longer durations of REM sleep deprivation (48 and 72 hr) impaired induction of 
LTP (Davis, Harding et al. 2003).  In addition, McDermott et al. (2003) showed that 
neuronal excitability was reduced in CA1 neurons and induction of LTP was 
inhibited after 72 hr of REM sleep deprivation (McDermott, LaHoste et al. 2003).  
 
Although previous investigations demonstrated disruption of LTP in isolated 
hippocampal slices following REM sleep deprivation, LTP in vivo may be affected 
differently due to REM sleep rebound and associated activity in endogenous 
neurotransmitter systems, influences which are lost during in vitro studies.  REM 
sleep rebound was first proposed by Dement (1960) to describe the increase in 
frequency and duration of REM sleep after instrumental REM sleep deprivation 
(Dement 1960).  It was suggested that REM sleep rebound occurs because the 
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REM sleep state has an important homeostatic role in the brain function and REM 
sleep loss has to be ‘repaid’ by a subsequent increase of REM sleep to maintain 
normal brain function (Jouvet 1994).  In 2003, Wetzel tested the effect of REM 
sleep rebound on memory in rats.  Rats were REM sleep deprived for 80 hr and 
then trained to learn a footshock-motivated brightness discrimination task in a Y-
maze.   After training, rats were allowed to freely sleep for 24 hr before a retention 
test. During post-training sleep, EEG activity was recorded to measure REM and 
non-REM sleep.  There was a significant increase in number and duration of REM 
sleep episodes in the REM sleep deprived group compared to the control group.  
Also, the REM sleep deprived group scored significantly better on the retention test 
and there was a positive correlation between REM sleep rebound value and 
retention test scores (Wetzel, Wagner et al. 2003).  These results show that REM 
sleep rebound after REM sleep deprivation has a positive effect on learning and 
memory.  
 
 
REM sleep is regulated by three major neurotransmitters, norepinephrine, 
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serotonin, and acetylcholine.  The noradrenergic (locus coeruleus) and the 
serotonergic (raphe nucleus) neurons in the brain stem are most active during 
waking and become progressively less active in the transition from non-REM (slow 
wave sleep) to REM sleep.  On the other hand, the cholinergic neurons in the 
thalamus are active both during waking and REM sleep.  During REM sleep 
deprivation, noradrenergic and serotonergic neurons continuously fire whereas 
cholinergic neurons decrease firing (Kalia 2006; Pal and Mallick 2007).  
 
The hippocampus receives input from all three of these neurotransmitter 
systems.  Serotonin receptors are found in the hippocampus and serotonin or 
serotonin receptor agonists have been shown to improve cognitive performance 
(Buhot 1997; Meneses 1999).  Norepinephrine, briefly superfused during high-
frequency stimulation in the rat hippocampal slice in vitro, produced a reversible 
increase in the magnitude, duration, and probability of induction of LTP in the CA3 
subfield.  Similar results were obtained with the β-adrenergic agonist, 
isoproterenol, whereas the β-adrenergic antagonist propranolol reversibly blocked 
long-term potentiation (Hopkins and Johnston 1984).  Acetylcholine also has a 
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direct effect on hippocampal synaptic plasticity.  Application of acetylcholine 
produced a gradually developing, long-lasting increase in the CA1 excitatory 
postsynaptic potential (Auerbach and Segal 1994).  Collectively, these results 
indicate that REM sleep deprivation alters the function of these three 
neurotransmitter systems and that altered activity in these systems can in turn 
modulate hippocampal function, synaptic plasticity, and memory.  
 
While long-lasting consequences of altered modulatory input to the 
hippocampus might be detectable in vitro, the full consequences may only be 
apparent when hippocampal function is assessed in vivo.  I, therefore, 
investigated the consequences of REM sleep deprivation on hippocampal LTP in 
vivo, to compare with previous findings from in vitro studies.  
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Materials and Methods 
 
Animals and REM sleep deprivation treatment 
 Male Sprague-Dawley rats (280-310 g) were subjected to REM sleep 
deprivation or control treatment. REM sleep deprived rats were placed individually 
on a small circular platform (10.5 cm diameter) in a water-filled tank (29 cm 
diameter).  The platform was positioned 2.5 cm above water (6 cm depth).  This 
procedure, the classic ‘inverted flower pot’ technique, selectively deprives rats of 
REM sleep (Horne and McGrath 1984): loss of muscle tone during REM sleep 
causes animals to contact the water and waken, but animals are not awakened out 
of non-REM sleep.  Rats were treated for five consecutive days, except for a 1hr 
period each morning (10.00-11.00 a.m.), when rats were removed and placed in a 
home cage consisting of a clear circular tank with standard animal bedding.  
Animals were weighed and rectal temperatures were taken during this 1hr period. 
During the remainder of this 1hr period animals spent the majority of the time 
grooming, eating and drinking; animals rarely slept.  Control rats were treated 
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identically to REM sleep-deprived rats, except the diameter of the platform was 
28.0 cm, allowing them to obtain normal REM sleep. Food and clean water were 
freely available throughout treatment. 
 
 
 
      
Figure 6. Control (left) and REM sleep deprivation (right) treatment using the 
‘inverted flower pot’ technique.  Control animals were housed on large 
platforms above water, which allowed REM sleep, whereas sleep deprived animals 
were kept on smaller platforms which prevented REM sleep.  Food and fresh 
drinking water were continually available.  Food was delivered through a tube 
attached to a wire cover, which has been removed to more clearly illustrate the 
relative sizes of the large and small platforms housing the animals. 
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Surgery  
 LTP was assessed in rats with chronic stimulating and recording electrodes 
implanted into the right hippocampus prior to treatment.  Rats were anesthetized 
(halothane inhalation followed by chloral hydrate 300mg/kg i.p.), and mounted in a 
stereotaxic instrument (ASI Instruments).  Two small holes were drilled for 
insertion of bipolar, teflon-insulated, stainless steel stimulating and recording 
electrodes into area CA1.  Three additional holes were drilled for placement of 
stainless steel anchor screws.  One of the anchor screws was used as an 
electrical ground point.  Sterotaxic coordinates for the stimulating electrodes were 
3.0 mm posterior to bregma, 2.0 mm lateral from the midline.  Coordinates for the 
recording electrode, inserted at 10° from vertical, were 4.5 mm posterior to bregma, 
4.0 mm lateral from the midline.  Electrodes were initially lowered 3.0 mm, with 
final depths adjusted by monitoring evoked field potentials so that the largest 
negative field excitatory post-synaptic potentials (EPSPs) were obtained.  After 
final positioning, electrode were secured with dental cement and placed into a 
plastic connector cap, which was fixed to the skull with dental cement. 
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Buprenophine (90 mg/kg, s.c.) was administered post-surgery for analgesia. 
Animals were allowed 7-10 days for recovery.  
 
Recording 
 Animals received an initial recording session prior to treatment to allow 
habituation to the recording apparatus.  All recordings were done in each animal’s 
home cage.  A flexible cable connected the plastic cap on the animal’s head to a 
constant current, isolated stimulator (WPI A360) and an a.c. coupled amplifier (WPI 
DAM50).  Field EPSPs were amplified (gain of 100-1000), bandpass filtered (0.1-
2000 Hz), digitized and stored on a personal computer. Recording sessions began 
with a 30-60 min adaptation period.  Next, an input-output curve was constructed 
by stimulation from subthreshold intensity to the intensity, which evoked a maximal 
response.  The stimulus intensity, which evoked a response at 50% of maximum 
was determined and used for the remainder of the recording session (3 hr). Test 
stimuli were delivered every 15s. 
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After the initial recording session animals were assigned to either the REM 
sleep deprivation or control condition, and treatment began the next day.  After 5 
days of treatment, two additional recording sessions were made on consecutive 
recovery days.  Recording on the first recovery day began approximately 1 hr 
following completion of treatment; the second recording session began 24 hr after 
the start of the first session.  After 30-60 min of adaptation recording, an input-
output curve was constructed, and the stimulus intensity was adjusted to evoke a 
response at 50% of maximum.  After a 30min baseline-recording period at the 
50% intensity, LTP induction was attempted, using ten 200 Hz, 100ms stimulus 
trains, delivered at a 30s inter-train interval.  I delivered high-frequency stimulation 
while animals were awake because previous studies showed that the best LTP was 
obtained when animals were awake or in the REM sleep state (Bramham and 
Srebro 1989).  Recording was continued for 3 hr following high-frequency 
stimulation.  
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On recovery day 2, animals were again connected for a second recording 
session.  The initial stimulus intensity was set to the intensity used during the LTP 
recording on recovery day 1, so I could determine if any LTP remained.  After 30-
60 min, an input-output curve was constructed, and the stimulus intensity was 
readjusted to evoke responses at 50% of maximum.  Following a 30 min baseline 
recording period at the 50% intensity, LTP induction was attempted with animals in 
a waking state.  Recordings were continued for 3 hr following high-frequency 
stimulation.  
 
Histology 
 Placement of stimulation and recording electrodes was verified by 
histological examination.  After completing all experimental procedures, animals 
were deeply anesthetized (halothane inhalation followed by chloral hydrate 750 
mg/kg, or Nembutal 100 mg) and perfused transcardially with formalin fixative.  
Brains were removed, sectioned, and thionin stained.  
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Statistical analysis 
 Field potentials were collected and EPSP slopes were determined using 
the WinWCP program (John Dempster, University of Strathclyde).  Additional 
analysis used Excel (Microsoft) and Origin (OriginLab).  All statistics are 
presented as mean ± one standard error of the mean.  Statistical significance was 
assessed by paired and unpaired t-test, as appropriate, with p<0.05 considered 
significant.  
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Results 
 
LTP was assessed in vivo on two consecutive recovery days following 5 
days of REM sleep deprivation or control treatment.  On recovery day 1, I found 
significant LTP for both the REM sleep-deprived and control conditions (see Fig. 7).  
Immediately after tetanization EPSPs were significantly increased in both REM 
sleep-deprived (169±27% of baseline, n=10, p<0.01) and control animals 
(181±39% of baseline, n=8, p<0.05).  There was no difference between the two 
groups at this time point (p>0.45).  At the end of the 3 hr post-tetanus recording 
period, hippocampal field EPSPs in REM sleep-deprived animals averaged 
120±9% of the pre-tetanus baseline (p<0.02).  For control animals, EPSPs were 
153±29% of baseline (p<0.05).  Although control animals showed numerically 
greater LTP, the difference between control and REM sleep deprived groups was 
not significant (p>0.15).  Pre-tetanus recordings on recovery day 2 allowed us to 
determine if any LTP remained at the 24 hr post-tetanus time point.  Although both 
REM sleep-deprived and control animals showed significant LTP at 3 h post-
tetanus, by 24 hr post-EPSPs were no longer different from pre-tetanus (p>0.03, 
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0.10 for REM sleep-deprived and control, respectively).  
 
Figure 7. Significant LTP was obtained in both REM sleep-deprived and 
control group on the first recovery day following treatment. EPSPs were 
measured as the slope of the initial negative going portion of the response and 
were normalized by the mean of the pre-tetanus (baseline) response. EPSPs were 
averaged over 5 min periods and are plotted relative to time of tetaniztion (at 0 
min). (A) REM sleep-deprived animals showed an immediated post-tetanic 
increase in field EPSP slope. Althought the potentiated EPSP declined 
substantially during the 3 hr post-tetanus recording, responses were significantly 
potentiated even at 3 hr post-tetanus (p<0.02) (B) control animals showed a similar
increase in field EPSP immediately follow
 
ing tetaniztion, which remained up to 3 hr 
anus (p<0.05), and there was no significant difference between REM sleep-
p>0.15). Error bars show ± one standard 
error of
 
post-tet
deprived and control animals at this time (
 the mean. 
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Although I found no differences between REM sleep-deprived and control 
animals on recovery day 1, differences emerged on recovery day 2 (see Fig, 8).  
The potentiation in REM sleep-deprived animals completely decayed over the
post-tetanus recording period (at 3 hr post-tetanus, EPSPs were 108±8% of 
baseline, p>0.15).  In contrast, control animals on recovery day 2 continued
demonstrate significant LTP: at 3 hr post-tetanus, EPSPs were significantly 
enhanced compared to baseline (127±8%, p<0.05), and the difference between 
control and REM sleep deprived was significant (p<0.05).  This difference in L
occurred despite equivalent initial post-tetanic increase in field EPSP slope of
 3 hr 
 to 
TP 
 
40±22% (REM sleep deprived) and 169±29% (control) of baseline (p>0.25) 
 
 
1
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Figure 8. LTP was impaired in REM sleep-deprived animals on recovery day 2. 
(A) REM sleep deprived animals showed an immediate post-tetanic increase in 
field EPSP slope, but the potentiated EPSPs steadily declined during the 3 hr post-
tetanus recording. After 3 hr, EPSP slopes were no longer different from baseline 
(p>0.15). (B) In contrast, control animals on recovery day 2 again showed LTP 
which was maintained throughout the post-tetanus recording at 3 hr post-tetanus, 
p<0.05), and which was significantly greater than in REM sleep-deprived animals 
(p<0.05). Error bars show ± one standard error of the mean. 
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Discussion 
I found that 5 days of REM sleep deprivation significantly impaired LTP in 
hippocampal area CA1 in vivo, but only on the second recovery day following 
treatment.  Three prior studies examined sleep deprivation for effects on 
hippocampal LTP (Campbell, Guinan et al. 2002; Davis, Harding et al. 2003; 
McDermott, LaHoste et al. 2003).  In each of these studies, LTP was assessed in 
vitro using the brain slice preparation. In one study (Campbell, Guinan et al. 2002), 
12 hr of total sleep deprivation was produced by forced locomotion.  The 
remaining two studies (Davis, Harding et al. 2003; McDermott, LaHoste et al. 2003) 
used selective REM sleep deprivation procedures (using the ‘inverted flower pot’ 
method) for up to 72 hr.  In this study, I induced 5 days (120 hr) of REM sleep 
deprivation using the ‘inverted flower pot’ method.  Despite the variations in 
duration of SD, my in vivo study and previous in vitro studies are in general 
agreement:  sleep deprivation inhibits LTP and selective REM sleep deprivation 
affects LTP persistence with little or no change in the maximal initial potentiation 
immediately following tetanization.  
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Although there is general agreement between my study and earlier in vitro 
studies, there are some differences.  I found significantly impaired LTP only on the 
second recovery day following treatment, whereas prior in vitro studies found 
impaired LTP on recovery day 1.  This difference might be explained by inputs to 
the hippocampus from serotonergic and noradrenergic nuclei.  Neurons in these 
nuclei show altered activity during REM sleep deprivation and during the REM 
sleep rebound which follows REM sleep deprivation (Porkka-Heiskanen, Smith et 
al. 1995; Asikainen, Toppila et al. 1997).  Asikainen et al. (1997) reported that 
serotonin metabolism in the rat brain including hippocampus was increased during 
SD (Asikainen, Toppila et al. 1997).  In addition, Porkka-Heiskanen et al. (1995) 
measured norepinephrine concentration in the hippocampus after REM sleep 
deprivation.  They found that norepinephrine concentrations were significantly 
increased after 72 hr of REM sleep deprivation (Porkka-Heiskanen, Smith et al. 
1995).  In addition, they showed an increase in tyrosine hydroxylase activity, a 
rate-limiting step in norepinephrine biosynthesis, and its mRNA levels after REM 
sleep deprivation (Porkka-Heiskanen, Smith et al. 1995).  Since changes in 
serotonin and norepinephrine activities can modulate LTP (Hopkins and Johnston 
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1984; Auerbach and Segal 1994), and changes in the activity of these systems 
occur during sleep deprivation, the absence of this modulatory input when LTP is 
examined in vitro might account for my finding that LTP is intact on recovery day 1 
in vivo, whereas previous in vitro studies found disrupted LTP at this time.  
  
My finding of disrupted LTP on recovery day 2 can be explained by reduced 
REM sleep rebound on recovery day 2.  In 2004, Machado, et al monitored sleep 
parameters during 96 hr of SD and during 4 days of recovery sleep.  They showed 
that the ‘inverted flower pot’ method significantly reduced REM sleep during SD 
treatment, and caused a significant REM sleep rebound only during the first 24 hr 
of recovery sleep (Machado, Hipolide et al. 2004).  Therefore, my finding of 
disrupted LTP on recovery day 2, when REM rebound is largely dissipated 
indicates an enduring disruption of LTP as a consequence of prior REM sleep 
deprivation.  This disruption of LTP could reflect a loss or inhibition of any of the 
components of the signaling pathway which is activated during LTP induction, 
including the NMDA receptor.  Recent findings indicate that NMDA receptor 
function and expression are, in fact, altered by sleep deprivation (Chen, Hardy et al. 
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2006; Kopp, Longordo et al. 2006; McDermott, Hardy et al. 2006).  My next series 
of experiments examined a possible role for growth hormone in linking sleep to 
hippocampal NMDA receptor function and expression.  
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Chapter 2 
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Introduction 
It is well known that sleep deprivation impairs cognitive function (Smith 
1995; Youngblood, Zhou et al. 1997; Wilson 2002; McDermott, LaHoste et al. 
2003).  In addition, there are bidirectional interactions between sleep and the 
endocrine system.  The plasma concentrations of many hormones display sleep-
related variation suggesting that sleep influences hormone secretion.  Growth 
hormone (GH) is the best documented hormone with a strong sleep-related 
secretory pattern.  GH is produced by anterior pituitary somatotroph cells.  
Synthesis and secretion of GH are controlled by two hypothalamic neurohormones; 
growth hormone-releasing hormone (GHRH), which stimulates, and somatostatin, 
which inhibits GH (Gotherstrom, Svensson et al. 2001).  Secretion of GH is 
strongly regulated by sleep.  Although GH is secreted throughout the day, the 
major surge of GH secretion occurs during sleep (Obal and Krueger 2004; Steiger 
2007).  It has been shown that sleep deprivation (SD) suppresses GH secretion.  
Kimura and Tsai (1984) studied GH secretion in rats. These authors found that the 
peak of GH secretion appeared during the onset of the sleep cycle and SD during 
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this period prevented the high-level GH pulse (Kimura and Tsai 1984).  A similar 
suppression of GH secretion is seen during SD in human subjects (Brandenberger, 
Gronfier et al. 2000).    
 
In peripheral tissues, GH is essential for somatic growth and metabolism. 
GH has both direct and indirect actions on target tissues.  Indirect effects of GH 
are mediated mainly by insulin-like growth factor 1 (IGF-1).  IGF-1 is produced in 
response to GH stimulation in the liver and at other sites of GH action.  IGF-1 in 
turn, feeds back on the hypothalamus and pituitary to inhibit GH release.  In 
addition to peripheral tissues, GH also has effects on the central nervous system 
(CNS).  As in peripheral tissues, the effects of GH on CNS can be either direct or 
indirect, mediated by IGF-1.  In the CNS, IGF-1 promotes cell proliferation, cell 
migration, and cell differentiation during brain development (Anlar, Sullivan et al. 
1999).  Circulating IGF-1 reaches the CNS from the peripheral blood stream by a 
specific carrier in the BBB (Pan, Yu et al. 2005).  However, IGF-1 is also produced 
locally in the brain suggesting that GH might stimulate brain tissues to produce 
IGF-1 within the CNS (Sun, Al-Regaiey et al. 2005).  GH, like IGF-1, can cross the 
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BBB (Johansson, Larson et al. 1995; Coculescu 1999; Pan, Yu et al. 2005; Aberg, 
Brywe et al. 2006) and the GH receptor (GHR) is found in several brain regions 
including the hippocampus.  GH effects on the brain can therefore be direct, 
indirect and mediated by circulating IGF-1, or indirect and mediated by IGF-1 
produced within the CNS (Lai, Emtner et al. 1991; Lobie, Garcia-Aragon et al. 
1993).  
 
Recent studies have shown that GH affects cognitive function.  Decreased 
GH release, with normal aging or with GH deficiency, is paralleled with cognitive 
impairment (Nyberg 2000; Aberg, Brywe et al. 2006).  Moreover, GH therapy in 
GH deficiency, or GH treatment of aged animals leads to improved learning and 
memory (Nyberg 2000; Ramsey, Weiner et al. 2004; Aberg, Brywe et al. 2006).  
For example, Le Greves, et at. (2006) treated hypophysectomized rats with 
recombinant human GH (rhGH) for 9 days.  GH-treated hypophysectomized 
animals showed improved performance in a behavioral test of memory using the 
Morris water maze (Le Greves, Zhou et al. 2006).  In a similar study using aged 
rats, Ramsey et al (2004) found improved spatial learning in aged (24 month old) 
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rats which were treated with porcine GH for 4 months compared to control aged 
rats treated with saline vehicle for 4 months (Ramsey, Weiner et al. 2004).  The 
positive effect of GH treatment on cognitive function could be a secondary effect of 
IGF-1.  Administration of IGF-1 also improves age-related spatial memory deficits 
(Sonntag, Lynch et al. 2000).  While GH and IGF-1 treatments both improve 
cognitive function, at least under conditions where endogenous hormone levels are 
decreased, the mechanisms underlying this improvement remain to be determined. 
 
Although the exact mechanisms linking GH to cognitive function are still 
unclear, recent evidence suggests that GH can directly influence synaptic function 
and trigger synaptic plasticity in the hippocampus.  In 2006, Mahmoud and Grover 
showed that acute application of GH onto hippocampal brain slices enhances 
excitatory synaptic transmission, indicating that GH can directly affect hippocampal 
synaptic function (Mahmoud and Grover 2006).  In addition, the signal 
transduction pathways stimulated by the GHR and by hippocampal LTP induction 
share molecular components.  The GHR is a member of the cytokine receptor 
superfamily.  GHR dimerization upon binding to GH stimulates association with 
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and activation of Janus kinase 2 (JAK2) (Lobie, Zhu et al. 2000).  Activated JAK2 
in turn is responsible for activating numerous signaling cascades including the 
signal transducers and activators of transcription (STAT), Ras/Raf/MEK1/MAPK, 
and insulin receptor substrate-1(IRS-1)/PI3 kinase pathways (Liang, Jiang et al. 
2000).  Some of the kinases activated during GH signaling are also activated 
during LTP induction.  For example, during LTP induction, NMDAR activation 
causes increased intracellular Ca2+ concentration which activates Ras and, in turn, 
activates MAPK.  Activation of MAPK then stimulates activation of the cAMP-
responsive element-binding protein (CREB), which is at least partially responsible 
for a late gene transcription and protein synthesis dependent phase of LTP (Lynch 
2004).  As in LTP, GH can also stimulate CREB activation (Lobie, Zhu et al. 2000) 
through the Ras-MAPK pathway (Winston and Hunter 1995).  In addition, the PI3-
kinase inhibitors, LY294002 and wortmannin, prevented LTP in rat hippocampal 
brain slices (Sanna, Cammalleri et al. 2002), suggesting that PI3-kinase which is 
activated in response to GH stimulation, is also involved in LTP.  
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In the hippocampus, N-methyl-D-aspartate receptors (NMDARs) play a 
critical role in LTP induction (Bliss and Collingridge 1993; Malenka and Nicoll 1999).  
The NMDAR is blocked by magnesium at resting membrane potentials, and only 
becomes activated during coincident membrane depolarization and glutamate 
binding.  Activated NMDARs are calcium permeable, and their function in LTP 
induction is to increase intracellular calcium level in postsynaptic cells.  Increased 
calcium concentration in postsynaptic cells leads to activation of CaMKII which, in 
turn, stimulates several downstream cellular signaling molecules that participate in 
LTP induction and maintenance.   
 
The functional NMDAR is a heteromeric structure composed of two NR1 
subunits and two NR2 (NR2A-D) subunits. The NR2 subunits are particularly 
important in shaping the functional properties of the receptor, affecting the kinetics 
of synaptic currents, interactions of the receptor with signal proteins, and the role of 
the receptor in LTP (Lynch 2004).  NR2 subunit composition has an important role 
in regulating binding of the receptor to intracellular scaffolding proteins and kinases.  
One family of scaffolding proteins, the membrane-associated guanylate kinases 
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including postsynaptic density (PSD)-95, contains PDZ domains responsible for 
binding and stabilizing NMDARs in the plasma membrane.  The C-terminal tail of 
the NR2A subunit binds to PSD-95, increasing its expression at the synapse while 
at the same time depressing synaptic expression of NR2B. During development, 
the overall expression of PSD-95 is increased, favoring an increase in NR2A and a 
decrease in NR2B at the synapse.  As a consequence, NR2B subunits are 
present at higher levels in hippocampal synapses during development, but NR2A 
subunits predominate in mature synapses (Sans, Petralia et al. 2000).   
 
In addition, NMDAR decay kinetics vary depending on the specific NR2 
subunit contained in the receptor.  These differences in decay (deactivation) 
kinetics have been investigated during rapid, brief glutamate application and also 
during synaptic release of endogenous glutamate.   In general, NR2D containing 
receptors produce responses with the slowest decay time, whereas NR2B and 
NR2C containing receptors display more rapid deactivation time.  NR2A 
containing receptors, like those that predominate in mature synapses, show the 
fastest decay time (Vicini, Wang et al. 1998; Cull-Candy and Leszkiewicz 2004).  
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Figure 9. NMDARs form as tetramers composed of two copies of NR1 and 
two copies NR2 (top).  Illustration of the different deactivation kinetics of the 
various NR2 subunits (bottom). The time constants of deactivation in response to 
a 10ms pulse of 1mM glutamate are roughly as follows; NR2A, 100 ms; NR2B and 
NR2C 250 ms; NR2D, 4 s. (Cull-Candy and Leszkiewicz 2004) 
 
 
The role of specific NR2 subunits in LTP induction is controversial.  For 
example, in hippocampal slices, selective pharmacological antagonism of NR2B 
subunits was reported to inhibit the induction of long term depression (LTD), a 
weakening of synaptic strength which can reverse LTP without affecting induction 
of LTP, whereas antagonism of NR2A subunits prevented the induction of LTP 
without affecting induction of LTD (Liu, Wong et al. 2004).  In contrast, over 
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expression of NR2B in the forebrains of transgenic mice enhanced hippocampal 
LTP without affecting LTD (Tang, Shimizu et al. 1999).  Although its role in LTP 
induction is equivocal, the NR2B subunit has an important role in targeting CaMKII 
to the postsynaptic membrane.  CaMKII undergoes rapid autophosphorylation 
following NMDAR-mediated calcium influx at postsynapses.  It has been shown 
that autophosphorylation of CaMKII induces high-affinity binding to the NR2B 
subunit in the postsynaptic membrane (Strack and Colbran 1998).  Upon binding 
to the NR2B subunit, CaMKII controls intracelluar substrate phosphorylation and 
affects regulation of the kinase by protein phosphatases, which in turn contribute to 
enhancement of synaptic strength (Strack, Choi et al. 1997).   
 
Since each “flavor” of NMADR may have a different role in synaptic function, 
previous studies have tested the effect of GH on NMDAR subunit expression.  GH 
treatment in chronic GH deficiency or aging alters the mRNA abundance of specific 
NMDAR subunit in the hippocampus.  In 2002, Le Greves et al. showed that 10 
days of GH treatment increased the mRNA levels of the GHR and the NR2B 
subunit in adult rats, but NR1 and NR2A subunit mRNAs were increased in aged 
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rats (Le Greves, Steensland et al. 2002).  On the other hand, mRNA for NR1, 
NR2A, and PSD-95 was increased after 9 days of GH treatment in 
hypophysectomized rats (Le Greves, Zhou et al. 2006).  These findings indicate 
that GH availability can regulate hippocampus synaptic function by changing the 
pattern of mRNA expression for specific NMDAR subunits 
 
Like GH, SD also affects hippocampal synaptic plasticity and hippocampal 
NMDAR subunit composition and function.  In 2005, McDermott et al. reported 
that NMDA R currents in hippocampal neurons were decreased following 72 h of 
SD, and NR1 and NR2A subunits were reduced in hippocampal synapses.  
Similar results were reported by Kopp et al. (2006), who showed that the ratio of 
NR2A to NR2B subunits was increased after SD, and this change in NR2A/NR2B 
ratio was reversed after recovery sleep.  Finally, Chen et al. (2006) showed that 
NMDAR1 subunit expression was reduced after 24h of SD.  These SD-induced 
changes in NMDAR function and expression may underlie the LTP deficit and 
learning and memory impairment following SD. 
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GH is normally released during sleep and SD greatly reduces circulating 
GH.  Because both GH and sleep regulate NMDAR expression and function in the 
hippocampus, I hypothesized that loss of normal GH secretion during SD might 
alter hippocampal NMDAR expression and function, and impair NMDAR-
dependent synaptic plasticity.  In addition, because GH treatment in GH deficiency 
improved cognitive function, I also hypothesized that GH treatment during SD 
would reverse the impairment of synaptic function caused by SD.  
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Materials and Methods 
 
Animals and treatment 
270-350g male Sprague-Dawley rats were divided into two groups for sleep 
deprivation (SD) or control treatment.  Rats were placed on small or large (10.5 or 
28cm diameter) platforms over water for 3 days SD or control treatment (Kim, 
Mahmoud et al. 2005).   Half of the rats in each group were injected with rhGH (1 
mg/kg/day; SD-GH, Cont-GH), and the other half received equivalent volume 
saline injections (SD-Sal, Cont-Sal).  rhGH or saline injections were given every 
morning (between 9 – 11am) during 3 days of SD or control treatment.  
 
Slice preparation 
Rats were sedated by CO2/air inhalation, and decapitated.  The brain was 
removed and placed into chilled artificial cerebrospinal fluid (ACSF) composed of 
124mM NaCl, 26mM NaHCO3, 3.4mM KCl, 1.2mM NaH2PO4, 2.0mM CaCl2, 
2.0mM MgSO4, 10mM glucose, pH7.35, equilibrated with 95% O2, 5% CO2.  The 
58 
 
 
 
brain was cut in half along the longitudinal fissure.  The hippocampus was 
removed from one of the hemispheres and immediately frozen on dry ice.  The 
other hemisphere was trimmed and glued to the stage of a vibrating microtome 
(Campden Instruments), immersed in chilled ACSF, and sectioned into 400µm thick 
coronal slices.  Transverse hippocampal slices were dissected free from 
surrounding structures, and stored at room temperature (20-22oC) in an interface 
holding chamber.  Individual slices were transferred as needed to a small volume 
(approximately 200µL) interface recording chamber with oxygenated ACSF (35°C, 
perfusion rate 1-1.5 mL/min).  
 
     
 
Figure 10. Preparation of rat hippocampal slices. Rat brains were collected and 
glued to the stage of a microtome to cut in sections. Hippocampal slices were 
isolated then incubated in an oxygenated chamber. 
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Electrophysiology 
LTP was assessed by field potential recording.  Extracellular potentials 
were recorded through low impedance (3-4MΩ) glass micropipettes filled with 
ACSF and placed into the stratum radiatum of area CA1.  Signals were amplified 
(gain 100) and filtered (0.05-3,000 Hz, or 0.1-10,000 Hz), then digitized (10-
100kHz; National Instruments) and stored on a personal computer using WinWCP 
software (Strathclyde Electrophysiology Software, John Dempster, University of 
Strathclyde).  Baseline responses were recorded for 15 min, and then theta burst 
stimulation (20 bursts, each burst consisting of 4 stimuli at 100Hz, with bursts 
repeated at 200msec intervals) was given to induce LTP.  Recordings were 
continued for 60min following LTP induction.  For each slice, EPSP slopes were 
measured and normalized relative to the mean slope during the pre-tetanus 
baseline, and then expressed as percentage change from the baseline.  For 
statistical analysis, the percent change in EPSP slope was averaged over the 25-
30 min and 55-60 min post-tetanus periods. 
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Figure 11. The recording chamber (left) and placement of recording and 
stimulating electrodes (right).  
 
 
 
 
 
Figure 12. Diagram of a transverse section through the hippocampus 
illustrating the positioning of the electrodes for field potential recording. 
Stimulating and recording electrodes were positioned in area CA1 stratum radiatum, 
which contains the Schaffer collateral branches of CA3 pyramidal neurons (Sch.). 
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Somatic whole cell patch clamp recordings obtained from CA1 pyramidal 
neurons by the method of Blanton et al. (1989) were used to record spontaneous 
excitatory postsynaptic currents (EPSCs).  Patch electrodes (3-4MΩ) were filled 
with 140 mM cesium gluconate, 10 mM sodium HEPES (N-[2-
hydroxyethyl]piperazine-N’-[2-ethanesulfonic acid]), and 3 mM MgCl2, adjusted to 
285-290 mOsm, pH 7.2.  Recordings were done in the continuous voltage clamp 
mode of an Axoclamp 2B (Axon Instruments).  Signals were amplified (gain 10) 
and low pass filtered (3 kHz), then digitized (10-100 kHz; National Instruments) and 
stored on a personal computer using WinWCP or WinEDR (Strathclyde 
Electrophysiology Software, John Dempster, University of Strathclyde) programs.  
Membrane potentials were corrected for a calculated liquid junction potential of 10 
mV.  EPSCs were recorded in low Mg2+ (50 µM) ACSF. EPSCs were recorded for 
a 5 to 10min baseline period, and then D-AP5 (50 µM) was added to block 
NMDAR-mediated currents.  Spontaneous EPSCs were detected and analyzed 
using the Mini Analysis program (Synaptosoft).  Detection threshold was set to 4 
times the RMS baseline noise level.  EPSCs from the baseline recording and after 
addition of D-AP5 were aligned and averaged separately.  The amplitude of the 
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NMDAR-mediated synaptic current was determined by comparing the mean EPSC 
half-width from the baseline period with the mean EPSC half-width after addition of 
D-AP5 
 
Synaptic membrane preparation and western blotting 
Synaptic membranes were obtained as described earlier (Grosshans, 
Clayton et al. 2002; Goebel, Alvestad et al. 2005).  Dounce homogenates were 
prepared from hippocampal tissues in sucrose buffer (SB) containing 10 mM Tris-
HCl (pH 7.4), 320 mM sucrose, and phosphatase and protease inhibitor cocktails 
(Sigma, Roche).  Homogenates were centrifuged at 1,000g for 10 min to remove 
nuclei and large debris (P1).  The resulting supernatant (S1) was centrifuged at 
10,000g for 15min to obtain a crude synaptosomal membrane fraction (P2).  The 
P2 was lysed hypo-osmotically in water containing phosphatase and protease 
inhibitors for 30 min and then centrifuged at 25,000g for 20 min to yield the 
synaptosomal membrane fraction (LP1).  Pellets were rinsed with cold SB after 
each centrifugation.  The final pellets were resuspended in RIPA buffer and frozen 
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at -80oC until further analysis.  
 
For western blotting, samples were diluted to load 30µg of protein onto 8% 
SDS-PAGE gels.  Proteins were separated by electrophoresis and transferred to 
nitrocellulose membranes.  Membranes were blocked at room temperature with 
3% ECL AdvanceTM blocking reagent (Amersham/GE Healthcare) in TTS (0.5% 
Tween20, 10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.2 mM EDTA).  Membranes 
were then incubated with primary antibody (to NR1, NR2A or NR2B) diluted in TTS 
either at room temperature for 1hour or overnight at 4oC.  After washing in TTS, 
membranes were incubated with horseradish peroxidase-conjugated secondary 
antibodies in TTS for 1 hour at room temperature or overnight at 4oC.  The blot 
was washed and proteins were detected on X-ray film using the ECL AdvanceTM 
system (Amersham/GE Healthcare).  Films were scanned and analyzed using 
Image J software (Wayne Rasband, NIMH).  Blots were stripped (Pierce 
RestoreTM stripping buffer) and reprobed for other NMDAR subunits and for PSD-
95. 
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Measurement of serum IGF-1 
Trunk blood was collected at the time of sacrifice of animals.  Blood was 
kept on ice for 30 min and then was centrifuged at 1000g for 15 min to separate 
serum.  Serum IGF-1 was measured by ELISA, following the manufacturer’s 
instructions.  
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Results 
Previous investigations have established that GH is released during sleep, 
and prevention of sleep in turn suppresses circulating GH.  If GH is a mediator of 
sleep effects on hippocampal synaptic function, then experimental restoration of 
GH to sleep deprived animals should reverse the effects of SD.  I used three 
experimental approaches to test this hypothesized role for GH.  First, I examined 
NMDAR-mediated synaptic currents using whole cell patch clamp recordings from 
hippocampal neurons.  Second, I measured NMDAR-dependent LTP in 
hippocampal brain slices.  Third, I measured NR subunit expression in 
hippocampal synaptosomal membranes.   
 
NMDAR synaptic currents were impaired by SD but rescued by GH treatment 
(Fig. 13) 
I recorded spontaneous EPSCs (sEPSCs) in CA1 pyramidal neurons in 
hippocampal slices prepared from animals after 3 days of SD or control (cont) 
treatment.  These animals received either daily injections of saline vehicle (Sal) or 
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daily injections of GH. NMDAR function was assessed by whole cell patch clamp 
recording of sEPSCs in low Mg2+ (50μM) ACSF containing γ−aminobutyric acid 
(GABA) receptor antagonists.  NMDAR function was assessed by comparing 
sEPSC half-width before and after D-AP5 (50μM) application.  In Cont-GH and 
Cont-Sal cells, sEPSC half-width was reduced significantly by D-AP5 (Cont-GH, -
23,1±4.0%, n=11; Cont-Sal, -25.0±2.8%, n=13).  In SD-Sal cells, sEPSC half-
width changed by only -15.1±2.4% (n=13, significantly different from Cont-Sal, 
p<0.05).  In SD-GH cells, sEPSC half-width was reduced by -24.3±2.7% (n=15, 
not significantly different from Cont-GH or Cont-Sal, but significantly different from 
SD-Sal, p<0.05). 
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Figure 13. NMDAR synaptic currents were impaired by SD but rescued by GH 
treatment. A. Averaged sEPSCs recorded from individual CA1 pyramidal neurons 
in each of the four experimental groups, before addition of D-AP5 (black) and after 
addition of D-AP5 (magenta). The decrease in EPSC duration after AP5 application 
indicates the magnitude of NMDAR-mediated synaptic current. D-AP5 reduced 
EPSC duration in all cells except for the cell from the SD-Sal group. B. Mean 
EPSC half-width before (Pre) and after addition of the NMDAR blocker (+AP5). 
Although EPSC half-width was significantly reduced by D-AP5 in all four groups, 
the effect was substantially smaller in cells from SD-Sal animals. C. Percentage 
change in EPSC half-width. Cells from SD-Sal animals showed significantly 
reduced change, indicating impaired NMDAR function. GH injection had no effect 
on cells from control animals, but GH completely restored NMDAR function in cells 
from sleep deprived animals. N's = 13 (Cont-Sal), 11 (Cont-GH), 13 (SD-Sal), 15 
(SD-GH). 
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LTP was impaired by SD but rescued by GH treatment (Fig. 14) 
I recorded evoked field excitatory postsynaptic potentials (EPSPs) in 
stratum radiatum of area CA1 to assess LTP in response to theta burst stimulation 
(TBS) of Schaffer collateral/commissural afferents.  Following a stable 15 min 
baseline recording period, each slice received TBS (20 bursts, 4 stimuli at 100Hz, 
with bursts repeated at 5Hz), which caused an immediate increase in EPSP slope.  
In Cont-Sal (n=10) and Cont-GH (n=8) slices, the EPSP slope remained 
potentiated throughout the post-tetanus period.  In Cont-Sal and Cont-GH slices, 
at 25-30 min post-tetanus, EPSP slopes were increased by 39±5.0% and 44±8.4% 
compared to baseline, and at 55-60 min post-tetanus, EPSP slopes were increased 
by 24±5.4% and 35.6±8.1%. 
 
In SD-Sal slices (n=7), LTP was greatly impaired: EPSP slopes were 
increased by only 16.9±2.8% at 25-30 min post-tetanus (p<0.05 compared to Cont-
Sal), and no potentiation was present at 55-60 min post-tetanus (-1.2±5.0% 
change in EPSP slope; p<0.05 compared to Cont-Sal).  However, in SD-GH slices 
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(n=10), LTP at both post-tetanus times was significantly greater than in SD-Sal 
slices (p<0.05).  In addition, there was no difference between SD-GH and control 
slices: at 25-30 min post-tetanus, EPSP slopes were increased by 29.9±4.6%, and 
at 55-60 min post-tetanus, EPSP slopes were increased by 25.8±8.5%. 
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Figure 14. LTP was significantly impaired after sleep deprivation, but was 
rescued by GH injection. A. LTP was significantly reduced in slices (n = 8) from 
the SD-Sal group compared to slices (n = 10) from the Cont-Sal group (p<0.01 at 
both 30 min and 60 min time points). Insets (top) show EPSPs from representative 
slices in Cont-Sal (black) and SD-Sal (red) groups. EPSPs were averaged over (1) 
the final 5 min of the baseline period and (2) the final 5 min of the recording. 
Calibration bars show 1 mV, 2 ms. B. In contrast, there were no significant 
differences in LTP between the SD-GH (n = 10) and Cont-GH groups (n = 11; 
p>0.10 at 30 min, p>0.25 at 60 min). In addition, although daily GH injections had a 
pronounced effect on LTP in slices from sleep deprived animals, there was no 
effect on LTP in slices from control animals (Cont-Sal vs Cont-GH, p>0.55 at 30 
min, p>0.25 at 60 min). Insets show EPSPs from representative slices in Cont-GH 
(blue) and SD-GH (orange) groups. EPSPs were averaged over 5 min periods at 
(1) the end of the baseline period and (2) the end of the recording. Calibration bars 
show 1 mV, 2 ms. 
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Synaptic NMDAR 2B subunit protein level was decreased by SD but restored 
by GH treatment (Fig. 15) 
To determine the subunit composition of synaptic NMDARs in the 
hippocampal synapse, I prepared synaptosomal membranes from whole 
hippocampus, and quantified subunit protein levels using immunoblotting.  Protein 
expression was quantified by film densitometry and normalized within each blot to 
the mean density of the Cont-Sal group.  Normalized values were averaged 
across blots.  There were no differences among the four conditions (all n's=5) for 
NR1 or NR2A subunit levels, nor were there differences in PSD-95 levels.  NR2B 
subunits were significantly decreased after SD (p<0.05 for SD-Sal compared to 
Cont-Sal).  Critically, GH treatment of SD animals restored NR2B subunit levels to 
normal (no difference between Cont-Sal and SD-GH, p>0.05).   
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Figure 15. Hippocampal NR2B subunit expression was decreased after sleep 
deprivation, but restored by GH injection. (A) Results from a representative 
experiment. Four animals were examined. NR2B expression (top row) was 
substantially reduced by sleep deprivation in saline injected animals, but was 
restored by GH injection, whereas NR2A and NR1 subunits (middle rows) were 
less affected. Subunit expression did not differ between control animals (GH or Sal 
injected), and also did not differ between control and SD-GH. There were no 
differences in PSD-95 levels. (B) NR2B subunit was significantly reduced (p<0.05) 
in the SD-Sal group compared to Cont-Sal, and was significantly restored by GH 
injection (p<0.05, SD-Sal vs SD-GH).  
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IGF-1 level was not normalized by GH treatment (Fig. 16) 
IGF-1 is produced by the liver and other target tissues in response to GH 
stimulation and IGF-1 in turn can alter brain and cognitive functions (Sonntag, 
Lynch et al. 2000).  To verify that GH/IGF-1 signals were reduced in my SD 
animals, and to investigate whether GH treatment during SD restores IGF-1 
production, I used ELISA to measure serum IGF-1 level in animals from each of my 
four experimental conditions.  As expected, IGF-1 was significantly reduced in 
SD-Sal animals (1659.0±228.4 ng/ml, n=10) compared to Cont-Sal (3171.7±293.0 
ng/ml, n=11, p<0001).  Surprisingly, GH treatment did not restore IGF-1 in SD 
animals, with IGF-1 remaining significantly reduced in SD-GH animals 
(1909.5±259.3 ng/ml, n=8) compared to Cont-GH animals (3000.5±284.03 ng/ml, 
n=7, p<0.02). 
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Figure 16. Serum IGF-1 was significantly reduced in SD animals regardless of 
whether saline or GH injections were given.  Two way ANOVA demonstrated 
significant main effects for treatment (SD vs Cont, p<0.001), but not for injection 
(GH vs Sal, p>0.80) ; there was no interaction between treatment and injection 
(p>0.45); n's = 7 - 11). 
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Discussion 
GH is released in a major surge during sleep (Kimura and Tsai 1984; Obal 
and Krueger 2004; Steiger 2007), and SD substantially reduces circulating GH 
(Kimura and Tsai 1984; Brandenberger, Gronfier et al. 2000). I hypothesized that 
loss of GH as a consequence of SD was responsible for the altered synaptic 
function which has been reported in the hippocampus after SD (Davis, Harding et 
al. 2003; McDermott, LaHoste et al. 2003; Chen, Hardy et al. 2006; Kopp, 
Longordo et al. 2006; McDermott, Hardy et al. 2006).  My findings confirm a 
critical role for GH in maintaining hippocampal synaptic function.  Hippocampal 
CA1 neurons had reduced NMDAR-mediated synaptic currents, reduced NMDAR-
dependent LTP, and reduced synaptic NR2B subunit expression.  Most importantly, 
restoring GH to SD animals caused recovery of NMDAR function and subunit 
expression.  NMDAR function and expression were not affected by GH injection in 
control animals, which were not subjected to the SD procedure, demonstrating that 
the effects seen in SD animals represent a specific reversal of the consequences 
of sleep loss, and not a general enhancement of NMDA R function and expression 
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by GH. 
The decrease in NR2B subunits in hippocampal synaptosomal membranes 
from SD animals may explain my observation of reduced NMDAR contribution to 
EPSC half-width.  The decay kinetics of NMDAR synaptic currents depend on 
NR2 subunit identity:  receptors composed of NR1 and NR2A subunits result in 
synaptic currents with faster decay times than receptors composed of NR1 and 
NR2B subunits (Vicini, Wang et al. 1998; Cull-Candy and Leszkiewicz 2004).  The 
decreased NR2B subunit abundance I saw after SD would have left more 
hippocampal synapses in SD animals with faster NMDAR synaptic current decay 
time constants and therefore shorter half-widths.  Restoration of normal NR2B 
subunit expression with GH treatment can also explain the recovery of EPSC half-
width that I observed in pyramidal neurons from GH injection SD animals.  The 
loss of NR2B subunits after SD, and the recovery of NR2B levels with GH 
treatment may also explain the changes in LTP that I report here.  In my study, 
LTP was deficient in hippocampal slices from SD animals, which also had a lower 
NR2B subunit level.  GH restoration to SD animals rescued LTP and NR2B 
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subunit expression in parallel.  Previous studies suggest a mechanism for this 
association between NR2B subunits and LTP.  NR2B is critical for targeting 
activated CaMKII – a downstream target for Ca2+ during LTP induction (Malinow, 
Schulman et al. 1989; Silva, Stevens et al. 1992) and loss or specific inhibition of 
NR2B containing NMDARs impairs LTP (Clayton and Browning 2001; Clayton, 
Mesches et al. 2002). 
 
My results showing that hippocampal synaptic impairment caused by SD 
was restored by GH treatment add to a growing literature on the role of GH in 
cognitive and memory functions.  In both humans and animal models, GH 
deficiency leads to a variety of cognitive impairments, including deficient memory 
function (Nyberg 2000; Aberg, Brywe et al. 2006).  GH restoration to GH deficient 
humans and animals in turn normalize cognitive and memory function (Deijen, de 
Boer et al. 1998; Arwert, Deijen et al. 2005; Le Greves, Zhou et al. 2006).  
Changes seen during normal aging further emphasize the critical role of GH/IGF-1 
in maintaining memory function.  Circulating GH and IGF-1 are decreased during 
aging (Corpas, Harman et al. 1993), and GH or IGF-1 treatment improves memory-
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dependent performance (Markowska, Mooney et al. 1998; Ramsey, Weiner et al. 
2004).  Aged rats show impaired hippocampal LTP (Geinisman, Detoledo-Morrell 
et al. 1995; Bergado, Fernandez et al. 1997), and hippocampal-dependent learning 
and memory (Ward, Oler et al. 1999; Ward, Stoelzel et al. 1999) that have been 
linked to decrease NR2B expression (Clayton and Browning 2001; Clayton, 
Mesches et al. 2002).  In 2002, Le Greves et al. showed that chronic GH 
treatment increased NR2B mRNA in adult rats, and increased NR1 and NR2A 
mRNAs in aged rats (Le Greves, Steensland et al. 2002).  These authors 
suggested that GH facilitates hippocampal function and enhances LTP in young 
adult rats by up-regulating NR2B gene transcription; however, they showed no 
change in NR2B subunit with GH treatment in aged rats.  In addition, mRNA levels 
of NR1, NR2A, and PSD-95 were increased by GH treatment in 
hypophysectomized rats, but there was no change in NR2B subunit expression (Le 
Greves, Zhou et al. 2006).  Although these results indicate that GH may regulate 
NMDAR composition differently under different circumstances, GH regulation of 
hippocampal memory-related functions through altered NMDAR expression is of 
general and considerable significance.  
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Many GH effects are mediated by IGF-1 produced by the liver and target 
tissues. Decreased GH release leads to reduced plasma IGF-1.  Effects of GH on 
hippocampal synaptic function or NMDAR expression could be mediated by IGF-1.  
In support of this possibility, Le Greves et al (2005) showed that repeated injections 
of IGF-1 increased NR2B mRNA levels in young (11 weeks) adult rats.  However, I 
found no change in serum IGF-1 concentration in GH treated animals, indicating 
that the GH effects I report here were not mediated through increased circulating 
IGF-1 (Le Greves, Le Greves et al. 2005).  A direct role for GH in altering 
hippocampal synaptic function is supported by our laboratory’s previous finding 
(Mahmoud and Grover 2006) that direct application of GH to in vitro hippocampal 
slices can enhance NMDAR mediated EPSP/Cs.  My finding that GH treatment 
failed to stimulate circulating IGF-1 does not rule out a potential role for local, 
hippocampal IGF-1 production (D'Ercole, Ye et al. 1996).   
 
GH regulation of IGF-1 production by the liver is well documented 
(Schwander, Hauri et al. 1983).  It was surprising, therefore, that GH treatment of 
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SD animals did not restore circulating IGF-1 levels.  Several factors could explain 
this lack of effect.  First, GH is not the only circulating hormone whose levels are 
altered by SD:  circulating thyroid hormone, insulin, corticosterone, leptin and 
ghrelin are all altered by SD (Steiger 2007).  Second, although IGF-1 expression 
is regulated by GH, circulating IGF-1 concentration is dependent on the presence 
of IGF binding proteins (IGF-BPs).  SD has diverse effects on metabolic function 
and hormone levels (Everson 1995; Copinschi 2005; Knutson, Spiegel et al. 2007), 
which in turn may alter production of IGF-1 and IGF-BPs, or decouple IGF-1 
production from GH (Miell, Taylor et al. 1993; Thissen, Ketelslegers et al. 1994; 
Schmid, Brandle et al. 2004).  Restoration of GH alone may not have been 
sufficient to restore control IGF-1 levels. 
 
Taken together, my data indicate that GH regulates hippocampal synaptic 
function.  When normal GH signals are lost during SD, NMDAR-mediated synaptic 
currents and NMDAR-dependent LTP are impaired, and this deficit in NMDAR 
function may reflect a specific loss of NR2B subunits from synaptic membranes.  
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Most critically, restoration of GH to SD animals rescued hippocampal NMDAR 
function and expression.  While sleep has long been recognized as an essential 
regulator of biological function, including brain function, the signals linking sleep to 
brain function have not been known.  In this study, I demonstrated a direct role for 
GH as a mediator between sleep and hippocampal function, establishing for the 
first time that GH is an essential link between sleep and brain function.    
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Chapter 3 
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Introduction 
  
 Sleep deprivation (SD) impairs learning and memory as well as synaptic 
plasticity in the hippocampus.  In addition, SD causes stress and stress itself can 
interfere with learning, memory, and LTP in the hippocampus.  Foy et al. (1987) 
tested the effect of stress on in vitro hippocampal LTP by subjecting animals to 
stress prior to the preparation of brain slices.  The animals were placed in a 
restraining tube, and then received tail shocks every minute for 30 min.  
Hippocampal slices were prepared immediately after stress.  LTP was significantly 
impaired in the animals which received uncontrollable stress (restraint + shock) 
(Foy, Stanton et al. 1987).  Similar results have been reported when animals were 
exposed to more natural stressors.  LTP in the CA1 area of hippocampus was 
suppressed when animals were food deprived (Diamond and Rose 1994) or 
exposed to a predator (Mesches, Fleshner et al. 1999).  In addition, acute stress 
caused by exposure to a novel environment enhances long term depression (LTD), 
a weakening of synaptic strength which can reverse LTP, and that last hours or 
days (Xu, Anwyl et al. 1997).  These studies showed that stress has negative 
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effects on hippocampal synaptic plasticity.  Therefore, when assessing effects of 
sleep deprivation on cognitive and brain function, it is important to distinguish 
between the effect of sleep loss itself and stress which may occur secondarily to 
the loss of sleep.  
 
One of the main neuroendocrine systems involved in the response to 
stressors is the hypothalamic-pituitary-adrenal (HPA) axis.  A stressful stimulus 
perceived by the senses and evaluated in the brain ultimately induces the release 
of corticotrophin-releasing hormone (CRH) from the hypothalamus.  CRH 
stimulates the release of adrenocorticotropic hormone (ACTH) from the pituitary 
and ACTH subsequently stimulates the release of glucocorticoids (cortisol in 
humans or corticosterone in rats) from adrenal cortex.  Glucocorticoids produced 
in the adrenal cortex then negatively feedback to inhibit both the hypothalamus and 
the pituitary gland (Steiger 2007).   
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Figure 17. Hypothalamic-pituitary-adrenal (HPA) axis 
 
Hippocampal function is strongly influenced by corticosterone.  The 
hippocampus contains two types of corticosterone receptors, mineralocorticoid 
receptors and glucocorticoid receptors.  Mineralocorticoid receptors have 10-fold 
higher affinity for corticosterone than glucocorticoid receptors, and they are 
saturated under basal conditions.  At high corticosterone levels, such as during 
periods of stress, there is additional binding to the glucocorticoid receptors.  
Activation of glucocorticoid receptors has been shown, in several studies, to 
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suppress LTP.  Pavlides, et al. (1993) administrated corticosterone over 21 days 
and showed LTP was impaired compared to vehicle controls.  They also showed 
that acute injection of corticosterone impaired LTP demonstrating that 
corticosterone has both chronic and acute effects on hippocampal synaptic function 
(Pavlides, Watanabe et al. 1993).  In 2003, Yamada, et al. used adrenalectomized 
animals to test the effect of stress induced elevations of corticosterone on 
hippocampal LTP.  LTP was tested in vivo shortly after acute restraint stress.  
Adrenalectomized rats did not show the normal stress-induced suppression of LTP 
(Yamada, McEwen et al. 2003).  
 
Sleep deprivation induced by the small pedestal (‘inverted flower pot’) 
procedure is generally acknowledged to be stressful because of the restricted 
mobility, periodic immersion in water and loss of sleep.  Hipolide et al. (2006) 
measured corticosterone level after 4 days of SD induced by small pedestal 
procedure.  Corticosterone levels were increased in sleep-deprived rats compared 
to control rats and remained elevated even after a 4 day recovery period (Hipolide, 
Suchecki et al. 2006).  Meerlo et al. (2002) also found increased corticosterone 
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levels after a shorter, 2 day, period of sleep deprivation.  In this study, SD was 
induced by confining the rats on a slowly rotating wheel, and blood samples were 
taken from the tail during the SD procedure.  Corticosterone levels were 
significantly increased after only 6 h of sleep deprivation and remained elevated 
until the end of the 48 h sleep deprivation (Meerlo, Koehl et al. 2002).  These 
results indicate that instrumental SD induction is stressful and causes increased 
corticosterone levels.  However, these studies also showed that corticosterone 
level was significantly lower in control animals that were placed either in a home 
cage or on non-rotating wheels, indicating that control treatment in these studies 
were less stressful.  Since corticosterone can affect synaptic function in the 
hippocampus, using an appropriate control group, one which shows comparable 
levels of corticosterone, allows isolation of the effect of sleep deprivation. 
 
An appropriate control group for studying effects of SD on hippocampal 
synaptic plasticity would be treated as similarly as possible to the SD group and be 
subject to equivalent stress, but have normal, or closer to normal, sleep.  A large 
pedestal procedure had been suggested as a control treatment for SD studies 
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(Plumer, Matthews et al. 1974).  Pulmer et al. tested memory in rats that were 
placed on different sizes of the pedestal (7, 11.5, and 15 cm diameter) for 5 days.  
They found that animals that were placed on 15 cm diameter pedestal had better 
memory then the animals placed on smaller pedestals. They suggested that larger 
pedestal can be used as a control group because the lager pedestal is still 
surrounded by water, reproducing the environment of the small pedestal.  But the 
large pedestal is less disruptive of sleep because the pedestal is big enough for 
animals to sleep without falling into water.  In further support of the large pedestal 
control, there was no difference in adrenal gland weight between the SD and large 
pedestal control animals, indicating equivalent levels of stress during both 
procedures (Vogel 1975).  Therefore, I used the large pedestal procedure as a 
control treatment in my previous studies to assess unique effects of SD.  In this 
experiment, I measured corticosterone level in control and sleep deprived animals 
to verify that stress levels were similar in both treatments. 
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Materials and Methods 
 
Measurement of serum corticosterone  
 Male Sprague-Dawley rats (280 – 310g) were sleep deprived for 1, 3, or 5 
days using the inverted flower pot technique (10.5 cm diameter).  Control animals 
were placed on a larger pedestal (28.0 cm diameter) which allowed them to obtain 
sleep for 1, 3, or 5 days.  After completing SD or control treatment, rats were 
anesthetized by halothane inhalation, than decapitated.  Trunk blood was 
collected at the time of sacrifice.  Trunk blood from rats that were treated with 
either GH or saline during 3 days of SD was also collected at the time of sacrifice 
(for detailed methods see Chapter 2). After collection, blood was kept on ice for 30 
min and then was centrifuged at 1000g for 15 min to separate serum.  Serum 
corticosterone was measured using OCTEIA Corticosterone EIA kits (American 
Laboratory Products Company) according to the manufacturer’s instructions.  
Samples and standards were loaded in duplicate on a 96-well plate coated with a 
polyclonal corticosterone antibody, along with HRP-labeled corticosterone.  The 
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plate was incubated overnight (4°C), washed and developed with a chromogenic 
substrate (3,3’,5,5’-tetramethylbenzidie).  Absorbance was determined on a 
microplate reader at 450 nm (reference 650 nm).  Corticosterone concentration in 
each sample was determined by comparison with the absorbance of known 
standard concentrations. 
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Results 
 
No difference in corticosterone level between SD and control treatment (Fig. 
18) 
 To determine if the differences between SD and control animals reported in 
Chapter 1 and 2 might have been caused by differences in stress level between 
SD and control treatments, I measured serum corticosterone levels, using ELISA, 
after 1, 3, or 5 days of treatment.  In SD treatment, corticosterone level was 
significantly increased from day 1 (64.4±17.8 ng/ml) to day 3 (266.3±55.4, p<0.05) 
and day 3 to day 5 (517.3±59.4, p<0.05).  However, the large platform control 
group also showed increased corticosterone level over 5 days of control treatment 
(67.6±23.9 ng/ml on day1; 178.3±41.9ng/ml on day3 and 436.9±31.0ng/ml on 
day5).  For control and SD animals, the difference across treatment days was 
significant (p<0.05 for day 1 vs. day 3, day 1 vs. day 5, and day 3 vs day 5; n=6 on 
days 1 and 3, and n=7 on day 5). Finally, there was no difference between SD and 
control treatment on any treatment day (all p>0.05) indicating that my SD and 
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control treatments produced equivalent levels of stress, and any difference 
between these groups therefore reflects effects of sleep deprivation.  
 
 
 
    
Figure 18. Circulating corticosterone concentration did not differ between SD 
and control animals after 1, 3, or 5 days of treatment. Although corticosterone 
concentrations increased across treatment days (p<0.05 for day 1 vs. day 3, and 
day 1 vs. day 5), concentrations were not different between SD and control animals 
on any day (all p>0.05).  On day 1 and 3, n=6 for both SD and control, and on day 
5, n=7 for both SD and control. 
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No differences in cotricosterone levels in GH and saline injected SD and 
control animals (Fig. 19) 
I also measured serum corticosterone, using ELISA, after 3 days of SD or 
control treatment, with daily GH or saline injections.  There were no significant 
differences in corticosterone concentration among these four conditions (p>0.15 for 
SD vs Cont, p>0.25 for GH vs Sal; two-way ANOVA).   For Cont-Sal animals, 
corticosterone concentration averaged 31.7±9.0 ng/ml (n=10), for SD-Sal animals, 
corticosterone concentration was 65.7±20.3 ng/ml (n=14), for Cont-GH 
corticosterone concentration was 26.4±10.2 ng/ml (n=6), and for SD-GH animals 
corticosterone averaged 33.8±13.6 ng/ml (n=8).   These data demonstrate that 
serum corticosterone was not affected by either treatment (SD or control) or 
injection (either GH or saline).  Although there were no significant differences, 
corticosterone concentration appeared to be highest in SD-Sal animals at 
65.7±20.3 ng/ml compared to concentrations between 26 and 34 ng/ml in the other 
three conditions.  This apparent difference, however, reflected the presence of two 
outliers within this group, and removing these outliers left a corticosterone 
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concentration of 37.5±7.4 ng/ml (n=12), similar to the means of the other groups. 
 
 
 
 
Figure 19. There were no differences in serum cotricosterone concentration 
between SD and Cont treatments, and between GH and saline injection 
groups. A two-way ANOVA revealed no main effect for treatment (SD vs Cont, 
p>0.15) and no main effect for injection (GH vs Sal, p>0.25). 
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Discussion 
 
SD may be confounded with stress, and stress disrupts LTP in the 
hippocampus (Foy, Stanton et al. 1987; Pavlides, Nivon et al. 2002).  
Corticosterone is released in response to stress from the adrenal cortex (Axelrod 
and Reisine 1984).  To determine if the effect of SD on synaptic plasticity was due 
to difference in stress level between SD and control, I measured serum 
corticosterone levels, using ELISA, after 1, 3, or 5 days of SD or control treatment.  
Corticosterone concentration was increased over 5 days of SD using the inverted 
flower pot technique.  However, I also observed equivalent elevations in control 
animals which were placed on a larger pedestal indicating that there was no 
difference in stress between the two groups.  In addition, there were no significant 
differences in corticosterone levels among the GH and saline injected animals that 
received either SD or control treatment.  These results demonstrate that 
differences in stress cannot explain the synaptic changes as I reported in Chapter 
1 and Chapter 2.  
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Although substantial evidence indicates the negative effect of stress-
induced corticosterone elevation on synaptic plasticity (Pavlides, Watanabe et al. 
1993; Yamada, McEwen et al. 2003), other data suggest that the relationship 
between corticosterone and synaptic plasticity is more complex.  For example, 
animals that can terminate experimentally administered shocks show elevated 
corticosterone levels similar to animals which cannot terminate the shock. However, 
LTP was not impaired in brain slices from the animals that were able to escape 
from the shock, whereas brain slices from animals that received uncontrollable 
shock showed impaired LTP (Shors, Seib et al. 1989).  Thus, although elevated 
levels of corticosterone are a critical determinant of the effect of stress on synaptic 
plasticity, an increase in glucocorticoid hormones alone does not impair LTP, and 
an interaction with other factors may be required to cause impaired synaptic 
plasticity.  The present study showed corticosterone was increased in both SD 
and control animals, but there was no impairment of synaptic plasticity in the 
control group (as shown in Chapter 1 and Chapter 2) demonstrating that 
corticosterone was not responsible for the synaptic impairment I observed following 
SD.   
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Conclusion 
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Chronic sleep deprivation (SD) is a common feature of several pathologies, 
including those directly related to sleep such as insomnia and obstructive sleep 
apneas.  In addition, SD can result from our modern around-the-clock lifestyle, 
increased work pressure, shift work and psychosocial stress.  Since it has been 
proposed that sleep may play some essential role in the processes of learning and 
memory, it is important to know if brain functions involved in learning and memory 
are affected by SD.  Previous studies have shown that sleep deprivation impairs 
cognitive function and synaptic plasticity in the hippocampus.  SD also alters 
sleep related neuroendocrine systems, like the GH/IGF-1 axis.  However, the 
relationship between these neuroendocrine systems and synaptic function during 
SD is not well established.  The purpose of this study was to determine the effect 
of SD on synaptic plasticity and the role of GH in regulating synaptic plasticity 
during SD.  My studies were divided into three stages. First, to compare with 
previous findings from in vitro studies, I investigated the consequences of 5 days of 
REM sleep deprivation on hippocampal LTP in freely behaving animals.  Second, 
to determine if decreased GH release during SD is responsible for synaptic 
function impairment, I treated animals with GH during 3 days of SD and tested 
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hippocampal synaptic functions after completion of treatment.  Third, since SD 
causes stress and stress in turn can cause synaptic function impairment, I 
compared stress levels by measuring corticosterone concentration in each 
treatment group of animals. 
 
 My results showed that hippocampal LTP was impaired after 5 days of SD.  
However, unlike the in vitro studies, the significant impairment was only seen on 
the second recovery day suggesting a possible compensation mechanism, such as 
REM sleep rebound, might be present in the in vivo condition.  I also showed that 
GH treatment during sleep deprivation prevented the impairment of synaptic 
function which normally follows SD.  My finding that NMDAR function was 
restored by GH treatment during SD is consistent with emerging evidence for a 
general role of GH in regulation of synaptic function.  I found no differences in 
serum corticosterone concentration between control and SD animals, indicating 
that the effects I observed after SD were not the result of stress or stress-induced 
changes in corticosterone.  Additional studies will be needed to fully elucidate the 
cellular mechanisms underlying the effects of GH on synaptic plasticity.  These 
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future studies will need to address, for example, the signaling pathways through 
which GH regulates NMDAR expression and function.  
 
 In summary, I have shown, for the first time, that GH acts as a signal linking 
sleep to maintenance of normal brain function.  The loss of normal GH signals 
impairs hippocampal synaptic functions involved in memory, and experimental 
restoration of GH rescues these functions even during continued sleep deprivation.  
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